1.
East. Mediterr. health j
; 26(6): 626-629, 2020-06.
Article
in English
| WHOIRIS | ID: gwh-368726
Subject(s)
COVID-19 , Emergency Treatment , Emergency Medical Services , Mediterranean Region , SARS-CoV-2
2.
ClinicalTrials.gov; 31/05/2021; TrialID: NCT04918875
Clinical Trial Register
| ICTRP | ID: ictrp-NCT04918875
ABSTRACT
Condition:
Covid19;COVID-19 PneumoniaPrimary outcome:
Proportion of patients receiving oxygen via each of various delivery devices.;Proportion of patients progressing to invasive mechanical ventilation;Total oxygen requirements in patients receiving oxygen via each of various delivery devices.Criteria:
Inclusion Criteria:
1. Suspected SARS-CoV-2 infection as determined by treating clinical provider, or
confirmed SARS-CoV-2 infection confirmed virologically in the lab by RT-PCR via
nasopharyngeal or oropharyngeal sample or by SARS-CoV-2 Ag-RDTs that meet the minimum
performance requirements of =80% sensitivity and =97% specificity compared to a NAAT
reference assay.
2. Receiving supplemental oxygen or showing clinical evidence of need for supplemental
respiratory support as reflected in a respiratory rate =30 breaths per minute or an
SpO2 = 90%, SpO2 < 94 % if any emergency signs are present
3. Admitted to health care facility
Exclusion Criteria:
1. Is not receiving oxygen or does not have clinical criteria for oxygen treatment
specified above oxygen therapy
2. Does not have suspected or confirmed COVID-19 (as per criteria above)
3. Patient younger than 12 years of age
4. Lack of commitment to full supportive care